Concepedia

Stephen E. O'Connor

SE

30

Publications

1.6K

Citations

21

H-Index

1985

Active since

Affiliations

Sanofi (France)(Current)

Southampton General Hospital

Laboratoire de Synthèse Organique

CNS Research (United States)

University of Southampton

Stephen E. O'Connor is an author at Sanofi (France) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1985–2009

30

Publications

30

Dopexamine: a novel agonist at peripheral dopamine receptors and β<sub>2</sub>‐adrenoceptors

R.A. Brown, J. Michael Dixon, J B Farmer et al. · British Journal of Pharmacology · 1985 · 202 citations · Full text

The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile

Bruno Poirier, Jean‐Pierre Bidouard, C. Cadrouvele et al. · Diabetes Obesity and Metabolism · 2004 · 200 citations

, , +16

Suramin is a slowly‐equilibrating but competitive antagonist at P<sub>2x</sub>‐receptors in the rabbit isolated ear artery

P. Leff, Beverley Wood, Stephen E. O'Connor · British Journal of Pharmacology · 1990 · 139 citations · Full text

SSR182289A, a selective and potent orally active thrombin inhibitor

J.M. Altenburger, Gilbert Lassalle, Mostapha Matrougui et al. · Bioorganic & Medicinal Chemistry · 2004 · 132 citations

, , +7

The effects of dopexamine on the cardiovascular system of the dog

R.A. Brown, J B Farmer, Janet C. Hall et al. · British Journal of Pharmacology · 1985 · 96 citations · Full text

Rows per page

1–5 of 30